Milan, Italy

Emilio Mussini


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Emilio Mussini

Introduction

Emilio Mussini is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address cardiovascular and renal disorders. With a total of two patents to his name, Mussini's work showcases his dedication to advancing medical science.

Latest Patents

Mussini's latest patents include "Pyridynecarboxylic esters of dopamine and of its N-alkyl derivatives" and "N.sub.1 -Acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds active on the cardiocirculatory system." The first patent focuses on the creation of pyridinecarboxylic esters of dopamine, which are salts with pharmaceutically acceptable organic or inorganic acids. These compounds are particularly useful in treating cardiovascular and renal disorders. The second patent involves new tetrahydroquinoline compounds that are active on the cardiocirculatory system, along with their pharmaceutically acceptable salts and compositions.

Career Highlights

Throughout his career, Mussini has worked with various companies, including Simes and Simes S.p.a. His innovative approach and expertise in pharmaceutical chemistry have positioned him as a key figure in his field. His patents reflect a commitment to improving health outcomes through scientific research and development.

Collaborations

Mussini has collaborated with notable professionals in the industry, including Vittorio Vecchietti and Giorgio Ferrari. These collaborations have likely contributed to the success of his inventions and the advancement of pharmaceutical science.

Conclusion

Emilio Mussini's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…